Free Trial

Inovio Pharmaceuticals (INO) News Today

Inovio Pharmaceuticals logo
$1.86 -0.06 (-3.13%)
Closing price 04:00 PM Eastern
Extended Trading
$1.91 +0.05 (+2.69%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Inovio Pharmaceuticals, Inc. stock logo
Short Interest in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Grows By 19.6%
Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) saw a significant increase in short interest in March. As of March 31st, there was short interest totalling 6,400,000 shares, an increase of 19.6% from the March 15th total of 5,350,000 shares. Based on an average daily volume of 851,900 shares, the days-to-cover ratio is presently 7.5 days. Approximately 17.6% of the company's shares are short sold.
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) have received an average recommendation of "Moderate Buy" from the five brokerages that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and three have
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals (NASDAQ:INO) Upgraded at StockNews.com
StockNews.com upgraded shares of Inovio Pharmaceuticals to a "sell" rating in a report on Friday.
Inovio Pharmaceuticals, Inc. stock logo
HC Wainwright Issues Positive Estimate for INO Earnings
Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Free Report) - HC Wainwright raised their Q1 2025 EPS estimates for Inovio Pharmaceuticals in a report issued on Wednesday, March 19th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post earnings per share of
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals (NASDAQ:INO) Price Target Lowered to $5.00 at Royal Bank of Canada
Royal Bank of Canada lowered their price objective on Inovio Pharmaceuticals from $6.00 to $5.00 and set a "sector perform" rating for the company in a research report on Wednesday.
Inovio Pharmaceuticals, Inc. stock logo
HC Wainwright Reiterates Neutral Rating for Inovio Pharmaceuticals (NASDAQ:INO)
HC Wainwright reaffirmed a "neutral" rating and issued a $3.00 target price on shares of Inovio Pharmaceuticals in a research report on Wednesday.
Inovio price target lowered to $5 from $6 at RBC Capital
Inovio reports Q4 EPS (65c), consensus (83c)
Inovio price target lowered to $12 from $18 at Citizens JMP
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals (NASDAQ:INO) Announces Quarterly Earnings Results, Beats Estimates By $0.23 EPS
Inovio Pharmaceuticals (NASDAQ:INO - Get Free Report) issued its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.69) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.92) by $0.23.
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals (NASDAQ:INO) Releases Quarterly Earnings Results, Beats Estimates By $0.23 EPS
Inovio Pharmaceuticals (NASDAQ:INO - Get Free Report) issued its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.69) EPS for the quarter, beating analysts' consensus estimates of ($0.92) by $0.23.
Inovio reports ‘promising’ interim results from DMAbs trial
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five analysts that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have given
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals (INO) to Release Quarterly Earnings on Wednesday
Inovio Pharmaceuticals (NASDAQ:INO) will be releasing earnings before the market opens on Wednesday, March 5, Financial Modeling Prep reports.
AN2 Therapeutics, Inc. (ANTX) Gets a Buy from JMP Securities
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives $12.40 Average Price Target from Brokerages
Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) have earned an average rating of "Moderate Buy" from the five research firms that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold rating and three have issued a buy
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) has earned an average rating of "Moderate Buy" from the five analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the comp
Inovio price target lowered to $3 from $5 at H.C. Wainwright
Inovio Pharmaceuticals, Inc. stock logo
HC Wainwright Cuts Inovio Pharmaceuticals (NASDAQ:INO) Price Target to $3.00
HC Wainwright dropped their price target on Inovio Pharmaceuticals from $5.00 to $3.00 and set a "neutral" rating on the stock in a report on Monday.
Inovio CEO sees 2025 to be ‘transformational year’
Inovio Pharmaceuticals, Inc. stock logo
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) has received a consensus rating of "Moderate Buy" from the four brokerages that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating and two have issued a buy rating on the company. T
Inovio Pharmaceuticals, Inc. stock logo
JMP Securities Reaffirms "Market Outperform" Rating for Inovio Pharmaceuticals (NASDAQ:INO)
JMP Securities reissued a "market outperform" rating and set a $18.00 price target on shares of Inovio Pharmaceuticals in a research report on Friday.
Inovio Pharmaceuticals Prices $30 Mln Public Offering With Warrants
Inovio announces common stock and warrants offering, no amount given
INOVIO Announces Proposed Public Offering
Get Inovio Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter.

INO Media Mentions By Week

INO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INO
News Sentiment

0.00

0.72

Average
Medical
News Sentiment

INO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INO Articles
This Week

2

3

INO Articles
Average Week

Get Inovio Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:INO) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners